Cargando...
Cisplatin versus non-cisplatin based first-line chemotherapy for advanced urothelial carcinoma previously treated with peri-operative cisplatin
INTRODUCTION: The optimal choice of first-line chemotherapy in urothelial carcinoma (UC) patients who relapse after receiving peri-operative cisplatin-based chemotherapy (PCBC) is unclear. We investigated outcomes with cisplatin re-challenge vs. a non-cisplatin regimen in patients with recurrent met...
Guardado en:
| Publicado en: | Clin Genitourin Cancer |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913522/ https://ncbi.nlm.nih.gov/pubmed/26589729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.10.005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|